Solid Subtype Predicts Early Bone Metastases in Sensitive EGFR-Mutated Lung Adenocarcinoma Patients After Surgery

被引：0

作者：

Xiong, A. ^{[1
]}

Li, C. ^{[1
]}

Xu, J. ^{[1
]}

Yang, X. ^{[1
]}

Nie, W. ^{[1
]}

Zhong, H. ^{[1
]}

Chu, T. ^{[1
]}

Zhang, W. ^{[1
]}

Zhong, R. ^{[1
]}

Pan, F. ^{[1
]}

Shen, Y. ^{[1
]}

Lou, Y. ^{[1
]}

Zhang, B. ^{[1
]}

Han, B. ^{[1
]}

Zhang, X. ^{[1
]}

机构：

[1] Shanghai Chest Hosp, Shanghai, Peoples R China

来源：

JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 10期

关键词：

Histologic subtype; non-small cell lung cancer; Distant metastasis;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

FP12.06

引用

收藏

页码：S966 / S967

页数：2

相关论文

共 27 条

[21] Current and Emerging Treatment Options for Patients with Metastatic EGFR-Mutated Non-small Cell Lung Cancer After Progression on Osimertinib and Platinum-Based Chemotherapy: A Podcast Discussion [J].

Patel, Sandip ;

Patel, Jyoti D. .

ADVANCES IN THERAPY, 2023, 40 (12) :5579-5590

[22] Current and Emerging Treatment Options for Patients with Metastatic EGFR-Mutated Non-small Cell Lung Cancer After Progression on Osimertinib and Platinum-Based Chemotherapy: A Podcast Discussion [J].

Sandip Patel ;

Jyoti D. Patel .

Advances in Therapy, 2023, 40 :5579-5590

[23] Combination of Whole-Brain Radiotherapy with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Improves Overall Survival in EGFR-Mutated Non-Small Cell Lung Cancer Patients with Brain Metastases [J].

Chen, Chien-Hung ;

Lee, Hsin-Hua ;

Chuang, Hung-Yi ;

Hung, Jen-Yu ;

Huang, Ming-Yii ;

Chong, Inn-Wen .

CANCERS, 2019, 11 (08)

[24] Impact of whole brain radiation therapy on CSF penetration ability of Icotinib in EGFR-mutated non-small cell lung cancer patients with brain metastases: Results of phase I dose-escalation study [J].

Zhou, Lin ;

He, Jiazhuo ;

Xiong, Weijie ;

Liu, Yongmei ;

Xiang, Jing ;

Yu, Qin ;

Liang, Maozhi ;

Zhou, Xiaojuan ;

Ding, Zhenyu ;

Huang, Meijuan ;

Ren, Li ;

Zhu, Jiang ;

Li, Lu ;

Hou, Mei ;

Ding, Lieming ;

Tan, Fenlai ;

Lu, You .

LUNG CANCER, 2016, 96 :93-100

[25] Real-World Study of EGFR-TKI Rechallenge With Another TKI After First-Line Osimertinib Discontinuation in Patients With EGFR-Mutated Non-Small Cell Lung Cancer: A Subset Analysis of the Reiwa Study [J].

Sonehara, Kei ;

Tateishi, Kazunari ;

Yoh, Kiyotaka ;

Usui, Kazuhiro ;

Hosomi, Yukio ;

Kishi, Kazuma ;

Naka, Go ;

Watanabe, Kageaki ;

Tamano, Shu ;

Uemura, Kohei ;

Kunitoh, Hideo .

THORACIC CANCER, 2025, 16 (02)

[26] The impact of EGFR-TKI use on clinical outcomes of lung adenocarcinoma patients with brain metastases after Gamma Knife radiosurgery: a propensity score-matched analysis based on extended JLGK0901 dataset ( JLGK0901-EGFR-TKI) [J].

Yomo, Shoji ;

Serizawa, Toru ;

Yamamoto, Masaaki ;

Higuchi, Yoshinori ;

Sato, Yasunori ;

Shuto, Takashi ;

Akabane, Atsuya ;

Jokura, Hidefumi ;

Kawagishi, Jun ;

Aoyama, Hidefumi .

JOURNAL OF NEURO-ONCOLOGY, 2019, 145 (01) :151-157

[27] The impact of EGFR-TKI use on clinical outcomes of lung adenocarcinoma patients with brain metastases after Gamma Knife radiosurgery: a propensity score-matched analysis based on extended JLGK0901 dataset (JLGK0901-EGFR-TKI) [J].

Shoji Yomo ;

Toru Serizawa ;

Masaaki Yamamoto ;

Yoshinori Higuchi ;

Yasunori Sato ;

Takashi Shuto ;

Atsuya Akabane ;

Hidefumi Jokura ;

Jun Kawagishi ;

Hidefumi Aoyama .

Journal of Neuro-Oncology, 2019, 145 :151-157